Product Program year 2024 Source: CMS Open Payments

Stravix Pl

MedicalSupply Extra Cellular Matrix

Open in the dashboard

General payments

$874,632

7,713 payments

Research payments

$0

0 payments

Through program year 2024, $874,632 in general payments and $0 in research payments were reported against Stravix Pl (Extra Cellular Matrix).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $118,156 2,738
2023 General $424,844 3,303
2022 General $331,632 1,672

Breakdown

Who paid General payments · program years 2022–2024
  1. Smith+Nephew, Inc. $874,632 7,713 payments
Top recipients General payments · program year 2024
  1. Anthony Ndu Orthopaedic Surgery · Philadelphia, PA $3,325 3% · 12 payments
  2. Charles Parks Podiatrist, Foot & Ankle Surgery · San Francisco, CA $3,300 3% · 1 payment
  3. Steven Regal Orthopaedic Surgery · Pittsburgh, PA $3,150 3% · 1 payment
  4. Allen Raphael Podiatrist · Smyrna, GA $2,790 2% · 2 payments
  5. Memorial Hermann Texas Medical Cntr Teaching hospital · TX $2,500 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Podiatrist, Foot & Ankle Surgery Podiatrist $35,932 33% · 489 practitioners
  2. Podiatrist $17,942 17% · 223 practitioners
  3. Surgery $9,532 9% · 197 practitioners
  4. Orthopaedic Surgery $8,539 8% · 65 practitioners
  5. Vascular Surgery Surgery $4,417 4% · 83 practitioners

The top 5 of 84 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Pennsylvania $29,126 25% · 336 recipients
  2. Tennessee $10,122 9% · 125 recipients
  3. Texas $9,119 8% · 162 recipients
  4. California $8,856 7% · 108 recipients
  5. Illinois $8,427 7% · 144 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

7,713 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record